ES2187947T3 - Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv. - Google Patents

Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.

Info

Publication number
ES2187947T3
ES2187947T3 ES98912441T ES98912441T ES2187947T3 ES 2187947 T3 ES2187947 T3 ES 2187947T3 ES 98912441 T ES98912441 T ES 98912441T ES 98912441 T ES98912441 T ES 98912441T ES 2187947 T3 ES2187947 T3 ES 2187947T3
Authority
ES
Spain
Prior art keywords
hiv1
hiv
procedure
sub0
hiv2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98912441T
Other languages
English (en)
Other versions
ES2187947T5 (es
Inventor
Frederic Donie
Elke Faatz
Barbara Upmeier
Eva Hoess
Eric Saman
Marie-Ange Buyse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26034683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187947(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19727943A external-priority patent/DE19727943A1/de
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2187947T3 publication Critical patent/ES2187947T3/es
Publication of ES2187947T5 publication Critical patent/ES2187947T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a un procedimiento para la diagnosis de una infección por HIV por medio de un inmunoensayo que detecta específicamente el antígeno p24 del antígeno HIV, HIV1-subO y/o el antígeno p26 del antígeno HIV2, al menos un anticuerpo contra la zona env del HIV1, HIV1-subO y/o HIV2 y al menos un anticuerpo contra la zona pol y/o gag del HIV1, HIV1-subO y/o HIV2. La invención se refiere además a equipos de reactivos y a tiras de prueba adecuadas para el procedimiento de diagnosis y a los anticuerpos monoclonales contra p24 y la utilización de los mismos.
ES98912441.7T 1997-03-10 1998-03-05 Procedimiento para la detección simultánea de antígenos de HIV y anticuerpos de HIV Expired - Lifetime ES2187947T5 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19709762 1997-03-10
DE19709762 1997-03-10
DE19727943 1997-07-01
DE19727943A DE19727943A1 (de) 1997-03-10 1997-07-01 Verfahren zur simultanen Bestimmung von HIV-Antigenen und HIV-Antikörpern
PCT/EP1998/001235 WO1998040744A1 (de) 1997-03-10 1998-03-05 Verfahren zur simultanen bestimmung von hiv-antigenen und hiv-antikörpern

Publications (2)

Publication Number Publication Date
ES2187947T3 true ES2187947T3 (es) 2003-06-16
ES2187947T5 ES2187947T5 (es) 2014-01-29

Family

ID=26034683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98912441.7T Expired - Lifetime ES2187947T5 (es) 1997-03-10 1998-03-05 Procedimiento para la detección simultánea de antígenos de HIV y anticuerpos de HIV

Country Status (8)

Country Link
US (1) US6593079B1 (es)
EP (1) EP0972198B2 (es)
JP (1) JP3534417B2 (es)
AT (1) ATE228248T1 (es)
AU (1) AU6727798A (es)
CA (1) CA2283058C (es)
ES (1) ES2187947T5 (es)
WO (1) WO1998040744A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
AU2004200155C1 (en) * 1999-03-04 2015-07-23 Bionor Immuno As HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
DE10059720A1 (de) 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
US6818392B2 (en) * 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
FR2882557A1 (fr) * 2005-02-25 2006-09-01 Centre Nat Rech Scient Epitopes de vih et composition pharmaceutique les contenant
US8324153B2 (en) 2008-05-06 2012-12-04 New York Blood Center, Inc. Antiviral cell-penetrating peptides
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP1933145B1 (en) * 2006-12-11 2011-09-28 AraGen Biotechnology Co. Ltd. Rapid immunochromatographic detection by amplification of the colloidal gold signal
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
DE3636540A1 (de) 1986-10-27 1988-04-28 Behringwerke Ag Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren
DE3705686C2 (de) 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
EP1369427A3 (en) † 1988-06-09 2004-05-12 Innogenetics N.V. HIV-3 retrovirus strains and their use
EP0386713B1 (en) 1989-03-09 1996-09-18 Abbott Laboratories Immunoassay for antibodies to HIV
JP2001504572A (ja) * 1992-04-09 2001-04-03 アボツト・ラボラトリーズ Ｈｉｖ抗原及びｈｉｖ抗体を検出するためのアッセイ
DE4236189A1 (de) 1992-10-27 1994-04-28 Boehringer Mannheim Gmbh Verfahren zur simultanen Bestimmung von Antigenen und Antikörpern
JP3604147B2 (ja) 1994-07-25 2004-12-22 ロシュ ダイアグノスティックス ゲーエムベーハー 金属キレート標識ペプチド
AU684992B2 (en) 1994-07-25 1998-01-08 Boehringer Mannheim Gmbh Hapten-marked peptides
CN1148578C (zh) 1994-07-25 2004-05-05 罗切诊断学有限公司 免疫测定特异抗体的方法、所用试剂、抗原及其用途

Also Published As

Publication number Publication date
WO1998040744A1 (de) 1998-09-17
EP0972198A1 (de) 2000-01-19
ES2187947T5 (es) 2014-01-29
AU6727798A (en) 1998-09-29
ATE228248T1 (de) 2002-12-15
EP0972198B1 (de) 2002-11-20
CA2283058A1 (en) 1998-09-17
CA2283058C (en) 2011-09-27
JP3534417B2 (ja) 2004-06-07
JP2001514749A (ja) 2001-09-11
US6593079B1 (en) 2003-07-15
EP0972198B2 (de) 2013-12-11

Similar Documents

Publication Publication Date Title
ES2187947T3 (es) Procedimiento para la determinacion simultanea de antigenos de hiv y anticuerpos de hiv.
US5705331A (en) HIV nucleocapsid protein capture assay and method of use
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
BR0210598A (pt) Complexo solúvel que compreende uma glicoproteìna retroviral de superfìcie
CA2224003A1 (en) Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
ATE128738T1 (de) Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.
AU5190793A (en) Base dissociation assay
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
ES2085631T3 (es) Inmunoensayo para la deteccion simultanea de anticuerpos del hiv-1, hiv-2, htlv-i y htlv-ii.
AR011954A1 (es) UN PROCEDIMIENTO PARA EL DIAGNOSTICO DE UNA INFECCION POR HIV MEDIANTE UN INMUNOENSAYO, PROCEDIMIENTO PARA LA DETECCION DE ANTICUERPOS CONTRA HIV,ANTICUERPOS MONOCLONALES CONTRA EL ANTIGENO p24 DEL HIV1, USO DE DICHOS ANTICUERPOS MONOCLONALES, UN KIT DE REACTIVOS PARA LA DETECCION DE UNA
ES2140821T3 (es) Deteccion de la produccion de anticuerpos.
Povolotsky et al. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
Blomberg et al. Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting
Vallari et al. Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2
RU2283497C1 (ru) ИММУНОФЕРМЕНТНАЯ ТЕСТ-СИСТЕМА ДЛЯ ИДЕНТИФИКАЦИИ СПЕКТРА АНТИТЕЛ К ВИЧ 1 И 2 ВЫЯВЛЕНИЯ АНТИГЕНА ВИЧ 1 (p24) "ДС-ИФА-АНТИ-ВИЧ 1 И 2, ВИЧ 1 ГРУППЫ О-СПЕКТР+АГ p24 ВИЧ 1"
Graham et al. Immunodominant epitopes of HIV-1 p17 and p24
Galli et al. Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients
Awad et al. Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay
AR015659A1 (es) Un procedimiento para la deteccion de anticuerpos contra el hiv y antigenos usados en el mismo.
WO1988007586A1 (en) Method for detection of antigens of a retrovirus associated with aids in serum and other body fluids
Krust et al. A sensitive dot immunobinding assay for the detection of antibodies specific for HIV
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
Fuentes et al. Follow-up of HIV-infected individuals by semiquantitative detection of antibodies to p24 in ELISA
Ubol et al. Anti-HIV positivity in Thailand: the usefulness of another ELISA test kit and Western blot as confirmatory tests